| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.31 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |